Health Canada drug identification number

DIN 02513099 — BRAFTOVI 75 MG

BRAFTOVI is a capsule of Encorafenib marketed by PFIZER CANADA ULC. The full Encorafenib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02513099
Brand name
BRAFTOVI
Active ingredient
Encorafenib
Strength
75 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
PFIZER CANADA ULC
Health Canada status
MARKETED
Drug class
BRAF kinase inhibitor

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.